Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision line appears in the study record history, updating the version from v3.6.5 to v3.6.6. This reflects a platform release update applied to the page rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-29T18:39:50.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.6.5) added to replace the previous v3.6.4, indicating the study record was updated to a newer version.
    Difference
    0.1%
    Check dated 2026-08-08T17:10:02.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study's history now includes a new revision entry labeled v3.6.4, and the previous revision v3.6.3 is removed from the log. This reflects an update to the record's revision history rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-07-25T10:21:55.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the record history, replacing the previous v3.6.2. This reflects a site-level update to the page rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:14.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.2) was added to the record history and the older revision (v3.6.0) was removed, updating the study record's version history.
    Difference
    0.1%
    Check dated 2026-06-27T00:10:53.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Adds the responsible party’s name and affiliation to the record history and introduces new metadata fields (Last verified, Last known status was, Revision: v3.6.0).
    Difference
    3%
    Check dated 2026-06-12T15:43:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.